In the near future, physicians may treat some cancer patients with personalized vaccines that spur their immune systems to attack malignant tumors. New research led by scientists at Washington University ...
23 hours ago
4.7 / 5 (3) | 0
Together with a team at the Erasmus Medical Center in Rotterdam, LMU researchers have developed a candidate vaccine directed against the avian flu virus H5N1 and have now carried out the first tests in humans.
Nov 25, 2014
not rated yet | 0